APA (7th ed.) Citation

MA, C., Q, G., SAC, V., N, R., MS, F., CCP, S., . . . M, S. (2021). Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 56, 101372. https://doi.org/10.1016/j.ghir.2020.101372

Chicago Style (17th ed.) Citation

MA, Czepielewski, et al. "Switching from Originator Recombinant Growth Hormone (Genotropin™) to Biosimilar (CRISCY™): Results from a 6-month, Multicentric, Non-inferiority, Extension Trial." Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society 56 (2021): 101372. https://doi.org/10.1016/j.ghir.2020.101372.

MLA (9th ed.) Citation

MA, Czepielewski, et al. "Switching from Originator Recombinant Growth Hormone (Genotropin™) to Biosimilar (CRISCY™): Results from a 6-month, Multicentric, Non-inferiority, Extension Trial." Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society, vol. 56, 2021, p. 101372, https://doi.org/10.1016/j.ghir.2020.101372.